IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
NCT04224389 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-05-08
Summary
Compare patients' feelings in terms of swallowing ability assessed by the overall score of MD Anderson Dysphagia Inventory (MDADI) 2 years after starting treatment between patients who have been treated with IMRT and those who were treated by transoral surgery for a squamous cell carcinoma of the early stage oropharynx.
Conditions
Interventions
- PROCEDURE
-
transoral resection
The technique of transoral surgery will be left to the choice of the surgeon according to the equipment and the experience of the team and will be gathered. The options are: transoral surgery robot-assisted, endoscopic laser transoral surgery, transoral laser surgery classical instruments. The exact description of the resected area will be collected. of the cross-sections will be made for extemporaneous analysis if necessary in lateral margins and deep until complete excision.
- RADIATION
-
IMRT
Intensity modulation radiotherapy (RCMI or IMRT) will be performed using techniques static or rotational (arctherapy, tomotherapy). Restraint is recommended with thermoformed mask
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-22
- Primary Completion
- 2031-06-30
- Completion
- 2031-06-30
Countries
- France
Study Locations
More Related Trials
-
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
NCT03660449 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Esophagectomy in Complete Responders to CCRT
NCT01740375 ·Status: TERMINATED ·Phase: PHASE3
-
Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy
NCT04508829 ·Status: UNKNOWN ·Phase: PHASE2
-
Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT06596954 ·Status: RECRUITING ·Phase: NA
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
NCT04437212 ·Status: UNKNOWN ·Phase: PHASE2
-
Dysphagia Assessment After Swallowing Sparing RadioTherapy
NCT03448341 ·Status: COMPLETED
-
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
NCT04019548 ·Status: RECRUITING ·Phase: PHASE3
-
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03731442 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
NCT02913066 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
NCT05596890 ·Status: UNKNOWN ·Phase: PHASE2
-
Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal Carcinoma
NCT06248879 ·Status: WITHDRAWN ·Phase: NA
-
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
NCT00559351 ·Status: TERMINATED ·Phase: PHASE3
-
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
NCT06446726 ·Status: RECRUITING ·Phase: PHASE2
-
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
NCT04481100 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
NCT07015489 ·Status: COMPLETED ·Phase: PHASE2
-
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
NCT05937438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074 ·Status: RECRUITING ·Phase: PHASE2
-
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
NCT03600831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
NCT02429622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma
NCT05432219 ·Status: UNKNOWN ·Phase: NA